Bilirubin: both villain and hero? (Biomedicine).Bilirubin Bilirubin The predominant orange pigment of bile. It is the major metabolic breakdown product of heme, the prosthetic group of hemoglobin in red blood cells, and other chromoproteins such as myoglobin, cytochrome, and catalase. , the bile pigment that yellows the skin of babies born with jaundice jaundice (jôn`dĭs, jän`–), abnormal condition in which the body fluids and tissues, particularly the skin and eyes, take on a yellowish color as a result of an excess of bilirubin. , is generally considered a toxic molecule. According to a new study, however, bilirubin may actually protect cells from dangerous oxygen-containing molecules called free radicals. Bilirubin forms during the breakdown of hemoglobin, the oxygen-carrying protein in blood cells, and can build up to high concentrations in the blood. Several lines of evidence indicate that bilirubin is toxic, but why then is there a specific enzyme that converts the seemingly harmless molecule known as bilverdin into bilirubin? Scientists puzzled by this question have unearthed Unearthed is the name of a Triple J project to find and "dig up" (hence the name) hidden talent in regional Australia. Unearthed has had three incarnations - they first visited each region of Australia where Triple J had a transmitter - 41 regions in all. data suggesting that bilirubin, when present at the right concentration, is helpful instead of harmful. A research team headed by Solomon H. Snyder Dr. Solomon H. Snyder (born December 26, 1938) is an American neuroscientist. Snyder graduated from Georgetown University in 1958 and Georgetown Medical School in 1962. of Johns Hopkins University School of Medicine The Johns Hopkins University School of Medicine, located in Baltimore, Maryland, USA, is a highly regarded medical school and biomedical research institute in the United States. in Baltimore reports that bilirubin protects brain cells growing in lab dishes from the damage typically caused by hydrogen peroxide, a free radical. The scientists compared normal cells with ones in which the bilirubin-making enzyme was inhibited. The normal cells were able to survive a dose of hydrogen peroxide 10,000 times greater than the lethal dose for the bilirubin-deprived cells. The investigators report their findings in an upcoming Proceedings of the National Academy of Sciences The Proceedings of the National Academy of Sciences of the United States of America, usually referred to as PNAS, is the official journal of the United States National Academy of Sciences. . Snyder and his colleagues also garnered evidence for a mechanism by which bilirubin, which is altered when it defuses free radicals, is recycled back into its original form. This reuse amplifies its protective powers. A protective role for bilirubin may explain previous findings that have linked low blood concentrations of the molecule to cancer, heart attacks, and other diseases, the scientists note. |
|
||||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion